FindTrial
Sign In

Clinical Data analysis of cancer patient treated in HBCH Sangrur.

Clinical outcome of common cancers treated with radical intent at HBCH Sangrur- A Retrospective Analysis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/026156
Enrollment
5000
Registered
2020-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

University of Pennsylvania Institute India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: No age limit for inclusion for this study. All patients treated with radical intent are eligible for this study

Exclusion criteria

Exclusion criteria: 1.Patients treated with palliative intent 2.Patients who are referred out and definitive treatment received elsewhere.

Design outcomes

Primary

MeasureTime frame
To report on the clinical outcome in terms of patient demographics, treatment details, treatment compliance, morbidity, toxicities and disease including survivalsTimepoint: No specific time line for follow-ups data collection.—

Secondary

MeasureTime frame
No secondary outcomeTimepoint: NA—

Countries

India

Contacts

Public ContactDr J P Agarwal

Tata Memorial Centre, Mumbai

agarwaljp@tmc.gov.in222417000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026